Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Virtual Congress 2020

Side effect management of old and new anti-tumour agents: ESMO Guidelines into practice

Checkpoint inhibitors: How to manage rare and life threatening irAE

Date

20 Nov 2020

Session

Side effect management of old and new anti-tumour agents: ESMO Guidelines into practice

Topics

Management of Systemic Therapy Toxicities;  Immunotherapy;  Supportive Care and Symptom Management

Tumour Site

Presenters

Christina Ruhlmann

Authors

C.H. Ruhlmann

Author affiliations

  • Oncology Department, OUH - Odense University Hospital, 5000 - Odense/DK

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Updates in oncological emergencies

Presenter: Alexandre Chan

Session: Side effect management of old and new anti-tumour agents: ESMO Guidelines into practice

Resources:

Slides

Webcast

LIVE Q&A

Presenter: Alexandre Chan

Session: Side effect management of old and new anti-tumour agents: ESMO Guidelines into practice

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.